Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Doxa Dental is a Swedish medical technology company that develops and manufactures advanced bioceramic materials for dental applications. The company is best known for its proprietary Ceramir technology, a bioactive platform that integrates with natural tooth structure to provide superior sealing and biocompatibility. Its flagship product, Ceramir Crown & Bridge, is a high-performance dental cement used globally for permanent restorations. Doxa's products are designed to be chemically stable, easy to handle, and tissue-friendly, reducing post-operative sensitivity. In late 2020, Doxa Dental was acquired by Directa AB, a member of the Lifco Group, which has expanded its distribution and market reach. The company continues to innovate within the bioceramic space, offering solutions for pediatric dentistry and restorative procedures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Doxa Dental.